These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15660783)

  • 1. Gabapentin-induced myoclonus in end-stage renal disease.
    Zhang C; Glenn DG; Bell WL; O'Donovan CA
    Epilepsia; 2005 Jan; 46(1):156-8. PubMed ID: 15660783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development or worsening of myoclonus associated with gabapentin therapy].
    Koide Y; Ikeda H; Inoue Y
    Rinsho Shinkeigaku; 2009 Jun; 49(6):342-7. PubMed ID: 19618843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A probable case of gabapentin-related reversible hearing loss in a patient with acute renal failure.
    Pierce DA; Holt SR; Reeves-Daniel A
    Clin Ther; 2008 Sep; 30(9):1681-4. PubMed ID: 18840374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gabapentin-induced myoclonus in an elderly with end-stage renal failure.
    Shea YF; Mok MM; Chang RS
    J Formos Med Assoc; 2014 Sep; 113(9):660-1. PubMed ID: 25103080
    [No Abstract]   [Full Text] [Related]  

  • 5. Pregabalin- and gabapentin-associated myoclonus in a patient with chronic renal failure.
    Healy DG; Ingle GT; Brown P
    Mov Disord; 2009 Oct; 24(13):2028-9. PubMed ID: 19642217
    [No Abstract]   [Full Text] [Related]  

  • 6. [Myoclonias secondary to gabapentin in a patient with chronic renal failure].
    Prieto-Pérez L; Montastruc J; García-Ruiz PJ
    Rev Neurol; 2011 Apr; 52(8):512. PubMed ID: 21425106
    [No Abstract]   [Full Text] [Related]  

  • 7. Myoclonus associated with the use of gabapentin.
    Asconapé J; Diedrich A; DellaBadia J
    Epilepsia; 2000 Apr; 41(4):479-81. PubMed ID: 10756416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gabapentin toxicity in patients with chronic kidney disease: a preventable cause of morbidity.
    Zand L; McKian KP; Qian Q
    Am J Med; 2010 Apr; 123(4):367-73. PubMed ID: 20362757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gabapentin-Induced myoclonus: case report.
    Ege F; Koçak Y; Titiz AP; Oztürk SM; Oztürk S; Ozbakir S
    Mov Disord; 2008 Oct; 23(13):1947-8. PubMed ID: 18702113
    [No Abstract]   [Full Text] [Related]  

  • 10. Gabapentin-induced severe myoclonus in a patient with impaired renal function.
    Holtkamp M; Halle A; Meierkord H; Masuhr F
    J Neurol; 2006 Mar; 253(3):382-3. PubMed ID: 16133721
    [No Abstract]   [Full Text] [Related]  

  • 11. Gabapentin supplemented with ropivacain block of trigger points improves pain control and quality of life in trigeminal neuralgia patients when compared with gabapentin alone.
    Lemos L; Flores S; Oliveira P; Almeida A
    Clin J Pain; 2008 Jan; 24(1):64-75. PubMed ID: 18180639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative myoclonus induced by gabapentin and pregabalin: A case series and systematic literature review.
    Kim JB; Jung JM; Park MH; Lee EJ; Kwon DY
    J Neurol Sci; 2017 Nov; 382():36-39. PubMed ID: 29111014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gabapentin-induced rhabdomyolysis in a patient with diabetic neuropathy.
    Bilgir O; Calan M; Bilgir F; Kebapçilar L; Yüksel A; Yildiz Y; Sari I
    Intern Med; 2009; 48(12):1085-7. PubMed ID: 19525604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary and rectal incontinence during gabapentin therapy.
    Iyer R; Egloff L; Fraas J; Harris JD
    J Support Oncol; 2008 Apr; 6(4):152. PubMed ID: 18491681
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug-induced encephalopathy secondary to non renal dosing of common medications in Two dialysis patients.
    Onuigbo MA; Nye D; Iloanya PC
    Adv Perit Dial; 2009; 25():89-91. PubMed ID: 19886325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gabapentin-induced coma in a patient with renal failure.
    Dogukan A; Aygen B; Berilgen MS; Dag S; Bektas S; Gunal AI
    Hemodial Int; 2006 Apr; 10(2):168-9. PubMed ID: 16623669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel long-term anticonvulsant treatment with gabapentin without causing memory impairment in mice.
    Blake MG; Boccia MM; Carcaboso AM; Chiappetta DA; Höcht C; Krawczyk MC; Sosnik A; Baratti CM
    Epilepsy Behav; 2010 Feb; 17(2):157-64. PubMed ID: 20079694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of gabapentin in migraine prophylaxis: an observational open label study.
    Vuković V; Lovrencić-Huzjan A; Bosnar-Puretić M; Demarin V
    Acta Clin Croat; 2009 Jun; 48(2):145-51. PubMed ID: 19928412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Movement disorders associated with the use of gabapentin.
    Reeves AL; So EL; Sharbrough FW; Krahn LE
    Epilepsia; 1996 Oct; 37(10):988-90. PubMed ID: 8822698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy, safety and effect on the quality of life of gabapentin in adult epilepsy--results of a prospective open-label quasi naturalistic Hungarian multicenter study (phase human-IV)].
    Rajna P; Szíjártó E
    Ideggyogy Sz; 2006 Sep; 59(9-10):361-72. PubMed ID: 17165379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.